Al Nahdha Hospital Research Study to Help Critical Care of COVID-19 Patients
Principal Investigator Dr Saud Al Harthi, Doctor of Medicine, Internal Medicine: Diabetes and Endocrinology, Al Nahdha Hospital,
Muscat: A research project was carried out to observe the clinical characteristics of confirmed COVID-19 patients admitted to Al Nahdha Hospital.
A total of 102 patients were in the study from the day of admission until the day of discharge or transfer to another tertiary care hospital for intensive care.
Led by Principal Investigator Dr Saud Al Harthi, Doctor of Medicine, Internal Medicine: Diabetes and Endocrinology, Al Nahdha Hospital, the project was funded under the COVID-19 research program of the Ministry of Higher Education, Research and Innovation (MoHERI).
According to Dr Saud Al Harthi, principal investigator of the research study, the main objective of this study was to map socio-demographic, clinical, biological and radiological characteristics, as well as treatment and clinical outcomes of confirmed cases of COVID. -19 at Al Nahdha Hospital in Oman.
In addition, factors associated with the severity of the disease have been identified. Data required for the study was retrieved from the electronic health information system from March 3 to May 9, 2020.
Dr Saud explained that the team looked at the parameters, including demographics (age, sex, nationality, job and benchmark institute) and risk factors (travel history, tobacco and alcohol consumption, obesity , medical history of comorbidities [diabetes, hypertension, coronary artery disease (CAD), asthma, chronic kidney disease (CKD), heart failure (HF), and any other chronic diseases]).
Treatment measures reviewed included antibiotics, antiviral therapy, corticosteroid therapy, respiratory assistance and other supportive therapies in accordance with the national COVID-19 guideline.
The research study said most of the patients, representing 84.3% of the total sample, had no travel history to countries with COVID-19 outbreaks.
“The majority of patients were non-smokers (85.3%) and non-alcoholics (87.3%). Obesity was only reported in 15.7% of patients, of which only 2% had coexisting diabetes, ”said Dr Saud.
“Diabetes and hypertension were detected in 39.2% and 36.3% of the study population, respectively, and common symptoms were a dry cough (78.3%), fever (76 , 5%) and shortness of breath (69.6%) ”Dr Saud clarified.
“About 19% of the study population required intensive care and diabetes and chronic arterial disease were significant predictors of the need for intensive care,” added Dr Saud.
“Despite some variation in initial symptoms, most patients with COVID-19 presented with respiratory symptoms where, depending on the severity of the disease, treatment included antibacterials, antivirals, heparin, and steroids,” he said. he declared.
The results of this study can be directed towards the screening of vulnerable patients who may require intensive care and initiate the required preventive management plans.